Peptide Library
Browse 28 peptides with detailed information on dosing, benefits, and protocols
5-Amino-1MQ
Body recomp via NNMT inhibition
Mechanism
Inhibits NNMT, shifts methyl/NAD metabolism
Typical dose
25-50mg
Cycle length
4-6 weeks
Frequency
Daily
Clinical benefits
Synergistic compounds
AOD-9604
Fat mobilization support
Mechanism
Lipolysis signaling via GH fragment
Typical dose
250-500 mcg
Cycle length
6-12 weeks
Frequency
Daily (AM fasted)
Clinical benefits
Synergistic compounds
ARA-290
Neuropathic pain & nerve healing
Mechanism
Innate repair receptor agonist, tissue-protective signaling
Typical dose
2-4mg
Cycle length
4-12 weeks
Frequency
Daily
Clinical benefits
Synergistic compounds
BPC-157
Body protection compound
Mechanism
Angiogenesis, NO signaling, fibroblast migration
Typical dose
250-500 mcg
Cycle length
4-6 weeks
Frequency
Daily
Clinical benefits
Synergistic compounds
Cartalax
Cartilage & joint support
Mechanism
Gene-expression normalization in chondrocytes
Typical dose
2mg
Cycle length
10-20 days
Frequency
Daily (pulse)
Clinical benefits
Synergistic compounds
DSIP
Sleep onset & circadian support
Mechanism
Modulates sleep-arousal networks via hypothalamic signaling
Typical dose
100-300 mcg
Cycle length
2-3 weeks
Frequency
Nightly (pre-bed)
Clinical benefits
Synergistic compounds
Epitalon
Circadian & longevity support
Mechanism
Telomere/clock-gene regulation, melatonin modulation
Typical dose
5-10mg
Cycle length
10-20 days
Frequency
Daily (pulse)
Clinical benefits
Synergistic compounds
GHK-Cu
Collagen synthesis & skin remodeling
Mechanism
Up-regulates collagen/elastin, down-modulates MMPs
Typical dose
2-3mg
Cycle length
8-12 weeks
Frequency
3x / week or Daily
Clinical benefits
Synergistic compounds
hCG
Testicular maintenance & fertility
Mechanism
Mimics LH, stimulates Leydig/theca cells
Typical dose
500-2000 IU
Cycle length
4-24 weeks
Frequency
2-3x / Week
Clinical benefits
Synergistic compounds
Ipamorelin
Clean GH secretagogue
Mechanism
Selective GHS-R agonist, GH release without prolactin/cortisol
Typical dose
200-300 mcg
Cycle length
8-12 weeks
Frequency
3-5x / week (pre-bed)
Clinical benefits
Synergistic compounds
Kisspeptin-10
HPG-axis support
Mechanism
Stimulates GnRH neurons, pulsatile LH/FSH release
Typical dose
50-750 mcg
Cycle length
4-12 weeks
Frequency
2-3x / Week
Clinical benefits
Synergistic compounds
KPV
Anti-inflammatory peptide
Mechanism
α-MSH fragment, NF-κB down-regulation, mast-cell stabilization
Typical dose
250-1000 mcg
Cycle length
4-8 weeks
Frequency
Daily
Clinical benefits
Synergistic compounds
L-Carnitine
Fat oxidation & endurance
Mechanism
Carnitine shuttle for fatty acid transport to mitochondria
Typical dose
200-400mg IM
Cycle length
4-8 weeks
Frequency
3-5x / week (IM - pre-training)
Clinical benefits
Synergistic compounds
MOTS-c
Mitochondrial peptide for metabolic flexibility
Mechanism
AMPK activation, metabolic flexibility enhancement
Typical dose
5-15 mg
Cycle length
4-8 weeks
Frequency
2-3x / Week
Clinical benefits
Synergistic compounds
NAD+
Foundational energy substrate
Mechanism
Universal cofactor for ATP and sirtuin activity
Typical dose
100-250 mg
Cycle length
Ongoing
Frequency
3-5x / Week
Clinical benefits
Synergistic compounds
P21
Neuroplasticity enhancer
Mechanism
BDNF upregulation, synaptic plasticity enhancement
Typical dose
500mcg - 1mg
Cycle length
4-8 weeks
Frequency
Daily (pre-training)
Clinical benefits
Synergistic compounds
Pinealon
CNS trophic support
Mechanism
Oligopeptide regulatory effects on brain tissue
Typical dose
10mg
Cycle length
10 days
Frequency
Daily (pulse)
Clinical benefits
Synergistic compounds
Retatrutide
Triple agonist for aggressive fat loss
Mechanism
GLP-1 (satiety), GIP (insulinotropic), glucagon (lipolysis) agonist
Typical dose
1-2mg weekly
Cycle length
12-24 weeks
Frequency
q2d - Weekly
Clinical benefits
Synergistic compounds
Selank
Anxiolytic & stress resilience
Mechanism
Tuftsin analog, GABAergic modulation, anti-inflammatory
Typical dose
200-600 mcg
Cycle length
14-28 days
Frequency
As needed
Clinical benefits
Synergistic compounds
Semaglutide
GLP-1 for weight loss & CV protection
Mechanism
GLP-1R agonism with long half-life
Typical dose
0.25-2.4mg
Cycle length
16-24 weeks
Frequency
q2d - Weekly
Clinical benefits
Synergistic compounds
Semax
Cognitive drive & focus
Mechanism
ACTH analog, BDNF up-regulation, dopaminergic modulation
Typical dose
300-600 mcg
Cycle length
10-14 days
Frequency
As needed
Clinical benefits
Synergistic compounds
Sermorelin
Pulsatile GH release
Mechanism
Pulsatile GH release from pituitary, modest IGF-1 rise
Typical dose
100-300 mcg
Cycle length
8-12 weeks
Frequency
3-5x / week (pre-bed)
Clinical benefits
Synergistic compounds
SS-31
Mitochondrial function optimizer
Mechanism
Binds cardiolipin, stabilizes cristae, improves electron transport
Typical dose
5-20mg
Cycle length
4-8 weeks
Frequency
3-5x / Week
Clinical benefits
Synergistic compounds
TB-500
Soft-tissue healing accelerator
Mechanism
Actin-sequestering, cell migration, angiogenesis
Typical dose
2-10mg weekly
Cycle length
4-8 weeks
Frequency
2-3x / week
Clinical benefits
Synergistic compounds
Tesamorelin
Visceral fat reduction via GH
Mechanism
Stimulates pituitary GH release, IGF-1 elevation, lipolysis
Typical dose
1-2mg
Cycle length
12-16 weeks
Frequency
3-5x / week (pre-bed)
Clinical benefits
Synergistic compounds
Thymosin-α-1
Immune modulation & post-viral support
Mechanism
Enhances T-cell function, upregulates MHC, re-balances Th1/Th2
Typical dose
1.6-3.2mg
Cycle length
6-12 weeks
Frequency
2-3x / Week
Clinical benefits
Synergistic compounds
Tirzepatide
Dual agonist for weight & T2D control
Mechanism
GLP-1 satiety/gastric delay + GIP insulinotropic effects
Typical dose
2.5-15mg weekly
Cycle length
16-24 weeks
Frequency
q2d - Weekly
Clinical benefits
Synergistic compounds
VIP
MCAS & dysautonomia support
Mechanism
VPAC receptor activation, anti-inflammatory, mast cell modulation
Typical dose
50-200 mcg
Cycle length
4-8 weeks
Frequency
1-2x / day
Clinical benefits
Synergistic compounds